Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey

dc.authorid0000-0002-3187-2317
dc.authorid0000-0003-4866-1695
dc.authorid0000-0002-0439-2502
dc.authorid0000-0002-0754-4655
dc.authorid0000-0001-5191-1072
dc.authorid0000-0003-2351-1367
dc.authorid0000-0002-6706-6915
dc.contributor.authorOzalp, Sabit Sinan
dc.contributor.authorTelli, Elcin
dc.contributor.authorOge, Tufan
dc.contributor.authorTulunay, Gokhan
dc.contributor.authorBoran, Nurettin
dc.contributor.authorTuran, Taner
dc.contributor.authorYenen, Mufit
dc.date.accessioned2025-05-10T19:32:26Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground: To evaluate the incidence, diagnosis and management of GTN among 28 centers in Turkey. Materials and Methods: A retrospective study was designed to include GTN patients attending 28 centers in the 10-year period between January 2003 and May 2013. Demographical characteristics of the patients, histopathological diagnosis, the International Federation of Gynecology and Obstetrics (FIGO) anatomical and prognostic scores, use of single-agent and multi-agent chemotherapy, surgical interventions and prognosis were evaluated. Results: From 2003-2013, there were 1,173,235 deliveries and 456 GTN cases at the 28 centers. The incidence was calculated to be 0.38 per 1,000 deliveries. According to the evaluated data of 364 patients, the median age at diagnosis was 31 years (range, 15-59 years). A histopathological diagnosis was present for 45.1% of the patients, and invasive mole, choriocarcinoma and PSTTs were diagnosed in 22.3% (n=81), 18.1% (n=66) and 4.7% (n=17) of the patients, respectively. Regarding final prognosis, 352 (96.7%) of the patients had remission, and 7 (1.9%) had persistence, whereas the disease was mortal for 5 (1.4%) of the patients. Conclusions: Because of the differences between countries, it is important to provide national registration systems and special clinics for the accurate diagnosis and treatment of GTN.
dc.identifier.doi10.7314/APJCP.2014.15.8.3625
dc.identifier.endpage3628
dc.identifier.issn1513-7368
dc.identifier.issue8
dc.identifier.pmid24870768
dc.identifier.scopus2-s2.0-84901989944
dc.identifier.scopusqualityQ3
dc.identifier.startpage3625
dc.identifier.urihttps://doi.org/10.7314/APJCP.2014.15.8.3625
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8234
dc.identifier.volume15
dc.identifier.wosWOS:000338633500049
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAsian Pacific Organization Cancer Prevention
dc.relation.ispartofAsian Pacific Journal of Cancer Prevention
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectGestational trophoblastic disease
dc.subjectgestational trophoblastic neoplasia
dc.subjectincidence
dc.subjectTurkey
dc.titleMulticenter Analysis of Gestational Trophoblastic Neoplasia in Turkey
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8234.pdf
Boyut:
314.05 KB
Biçim:
Adobe Portable Document Format